{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-26-000037","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2026-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.919591+00:00","generated_at":"2026-05-16T10:18:14.471538+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Boston Scientific to acquire Penumbra for $374 cash or 3.8721 BSX shares per share (73.26% cash/26.74% stock mix)","bullets":["Penumbra shareholders elect cash ($374/share) or stock (3.8721 BSX shares/share); proration targets 73.26% cash, 26.74% stock.","Penumbra termination fee $525M if superior proposal accepted; BSX pays $900M if regulatory blocks after approval.","Closing conditions include Penumbra stockholder vote, HSR clearance, S-4 effectiveness, and no material adverse effect.","Outstanding Penumbra options and RSUs convert to cash/BSX stock based on formulas; certain RSUs assumed by BSX.","Transaction expected to close in H1 2026, subject to conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-26-000037","json":"https://secwatch.observer/filing/0000947871-26-000037.json","markdown":"https://secwatch.observer/filing/0000947871-26-000037.md","text":"https://secwatch.observer/filing/0000947871-26-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000094787126000037/0000947871-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000094787126000037/ss5822815_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:18:14.471538+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd302a40bc8402ee1ea97e44e130af8de36083cf","claim":"BOSTON SCIENTIFIC CORP entered into Agreement and Plan of Merger with Penumbra, Inc. (effective 2026-01-14).","evidence_excerpt":"On January 14, 2026, Boston Scientific Corporation, a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Pinehurst Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Merger Sub ”), and Penumbra, Inc., a Delaware corporation (“ Penumbra ”), providing for the merger of Merger Sub with and into Penumbra (the “ Merger ”), with Penumbra surviving the Merger as a wholly owned subsidiary of the Company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885725/000094787126000037/0000947871-26-000037-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Penumbra, Inc."},{"label":"Effective","value":"2026-01-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}